Slide 1: Nuchev Limited FY23 Results and Business Update
Nuchev Limited FY23 Results and Business Update 31 August 2023
Slide 2: Agenda
Agenda 01 Our Purpose 02 Our growth strategy 03 FY23 operating and financial review 04 H&S distribution agreement and strategic partnership 05 Focusing on our future Greg Kerr Chief Executive Officer
Slide 3: Our Purpose
Our Purpose Functional foods for a better life We are committed to improving families’ lives Demonstrated by Leadership in premium digestion and immunity • Backed by science • Fuelled by consumer led innovation • World class ingredients Supported through Premium nutrition • Consumer endorsement • Go
Slide 4: Our growth strategy
Our growth strategy Greg Kerr Chief Executive Officer
Slide 5: Our growth strategy
Our growth strategy Functional foods for a better life Leading in premium digestion and immunity nutritional products WHAT WE DELIVER TODAY Future focus for premium di mmunityei 55 nutrition. multiple ca @ Product Brand Supply chain Distribution ASK listed innovation builders excellence network acce
Slide 6: FY23 Operating and financial review
FY23 Operating and financial review
Slide 7: FY23 Key performance metrics
FY23 Key performance metrics FY23 FY22 % change Commentary ▪ Oli6® sales volume1 and revenue 1 (excluding sales of raw material Volume (MT) 1 230 216 +6.5% ingredients) in FY23 increased by 6.5% and 3.5% pcp3, respectively ▪ Adjusted EBITDA2 improved $2.8m or 27% pcp Oli6® sales revenue (excluding r
Slide 8: FY23 financial and operational performance
FY23 financial and operational performance Volumes1 (Metric Tonnes) Higher volumes1 250 230 215 ▪ Total sales volumes increased in H2 FY23 200 117 ▪ FY23 sales volumes up 6.5% pcp2 150 106 100 Increased Oli6® sales revenue1 50 113 109 ▪ FY23 revenue from Oli6® sales (excluding sale of raw material -
Slide 9: FY23 Adjusted EBITDA
FY23 Adjusted EBITDA $ millions FY23 FY22 Sales revenue1 up Oli6 Sales Revenue (excluding raw material sales) 7.5 7.2 ▪ Oli6® sales revenue increased $256k or 3.5% pcp2 Cost of sales (excluding raw material sales) (5.0) (4.5) Gross Profit 2.5 2.8 ▪ ANZ sales increased $1.15m or 26% pcp, with increas
Slide 10: Improved operating cashflow
Improved operating cashflow Net cash flows used in operations Disciplined cashflow and working capital management has delivered substantial cash savings 10.0 $8.3m Disciplined cost control measures combined with improved working 8.0 2.4 capital management practices, enabled the Group to reduce its n
Slide 11: Balance Sheet
Balance Sheet $ millions 30 June 2023 30 June 2022 Cash and short term deposits 7.5 5.1 Cash increased $2.4m pcp1 Trade and other receivables 0.7 1.6 ▪ Closing cash position of $7.5m at 30 June 2023, an improvement of $2.4m Prepayments 1.1 0.5 or 47% pcp1 Inventories 5.3 9.4 Current assets 14.6 16.6
Slide 12: Strategic partnership with H&S Group
Strategic partnership with H&S Group ▪ A strategic partnership to drive market growth, brand equity and shareholder value. Leverage H&S experience and ▪ The FY23 Capital Raise will provide Nuchev with the funds to execute networks to Enhance brand its growth strategy to scale, widen its offering thr
Slide 13: H&S Distribution Agreement and Strategic Partnership
H&S Distribution Agreement and Strategic Partnership
Slide 14: H&S company overview
H&S company overview Since 2009, H&S has built a comprehensive distribution network (off-line and online), forging the path to become one of Australia’s largest local and export wholesalers for infant formula, vitamins and supplements, skincare and personal care into China, Hong Kong, Macau, Vietnam
Slide 15: Focusing on our future
Focusing on our future Greg Kerr Chief Executive Officer
Slide 16: Repositioning strategy for profitable scalable growth
Repositioning strategy for profitable scalable growth MAINTAIN OUR CURRENT PURPOSE PURPOSE FUNCTIONAL FOODS FOR A BETTER LIFE Current Future Leading premium digestion, immunity and wellness PRODUCT Single minded focus on goat nutritionals in multi-categories POSITIONING Diversified portfolio of prof
Slide 17: Disclaimer
Disclaimer • This presentation has been prepared for publication in Australia and may not be released to US wire services or distributed in the United States. In particular, this presentation does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States
Slide 18: nuchev
-_ nuchev